Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -29.67M
March 31, 2026 -23.15M
December 31, 2025 -36.45M
September 30, 2025 -31.28M
June 30, 2025 -50.21M
March 31, 2025 -47.91M
December 31, 2024 -51.30M
September 30, 2024 -55.51M
June 30, 2024 -60.56M
March 31, 2024 -51.74M
December 31, 2023 -23.55M
September 30, 2023 -35.70M
June 30, 2023 -40.04M
March 31, 2023 -37.61M
December 31, 2022 -42.90M
September 30, 2022 -48.62M
June 30, 2022 -38.48M
March 31, 2022 -51.48M
December 31, 2021 -37.43M
September 30, 2021 -43.13M
June 30, 2021 -41.66M
March 31, 2021 -49.56M
December 31, 2020 -41.48M
Date Value
September 30, 2020 -56.59M
June 30, 2020 -32.70M
March 31, 2020 -56.24M
December 31, 2019 39.33M
September 30, 2019 -29.13M
June 30, 2019 -27.32M
March 31, 2019 -29.72M
December 31, 2018 -0.088M
September 30, 2018 -8.779M
June 30, 2018 -18.12M
March 31, 2018 -23.47M
December 31, 2017 -25.36M
September 30, 2017 -28.73M
June 30, 2017 -26.52M
March 31, 2017 69.14M
December 31, 2016 -14.03M
September 30, 2016 -17.75M
June 30, 2016 -11.06M
March 31, 2016 -10.57M
December 31, 2015 -8.369M
September 30, 2015 -12.13M
June 30, 2015 19.91M
March 31, 2015 -6.248M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. -107.91M
Geron Corp. -16.05M
Halozyme Therapeutics, Inc. 236.72M
Novavax, Inc. -73.40M
AVITA Medical, Inc. -3.742M